Efficacy of Riluzole in Hereditary Cerebellar Ataxia: a Randomized Double-blind Placebo-controlled Trial.
Phase of Trial: Phase II/III
Latest Information Update: 01 Oct 2015
At a glance
- Drugs Riluzole (Primary)
- Indications Cerebellar ataxia
- Focus Therapeutic Use
- 20 Apr 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov
- 19 Jul 2011 Planned End Date changed from 1 May 2012 to 1 May 2013 as reported by ClinicalTrials.gov.
- 19 Apr 2010 New trial record